This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) shed 1.40% to $92.53 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.09% to 6,840.51 and Dow Jones Industrial Average  falling 0.38% to 47,560.29.
This was the stock's seventh consecutive day of losses.
Boston Scientific Corp. closed 15.50% below its 52-week high of $109.50, which the company reached on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 0.69% to $121.25, Medtronic PLC (MDT) fell 1.62% to $99.62, and Stryker Corp. (SYK) fell 1.24% to $349.23.
Trading volume (12.7 M) eclipsed its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 9, 2025.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
12-09-25 1636ET

<p>Boston Scientific Corp.'s stock fell 1.40% to $92.53 on Tuesday, marking its seventh consecutive day of losses. The stock is 15.50% below its 52-week high. Competitors Abbott Laboratories, Medtronic PLC, and Stryker Corp. also saw declines. Trading volume was higher than the 50-day average. The S&P 500 and Dow Jones also fell slightly.</p>

Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors